Progression of myocardial remodeling and mechanical dysfunction in the spontaneously hypertensive rat

Ian J LeGrice1, Adèle J Pope, Gregory B Sands

  • 1Department of Physiology, University of Auckland, Auckland, New Zealand.

Insights

Hypertensive heart disease (HHD) progression involves myocardial remodeling. Disrupted cardiac collagen structure, not softening, contributes to impaired systolic function in heart failure (HF).

Area of Science:

  • Cardiovascular Physiology
  • Cardiac Remodeling
  • Extracellular Matrix Biology

Background:

  • Hypertensive heart disease (HHD) leads to heart failure (HF) through myocardial remodeling.
  • The three-dimensional organization of the cardiac extracellular matrix in HHD-induced HF is not fully understood.
  • Quantifying matrix changes is crucial for understanding HF development in HHD.

Purpose of the Study:

  • To investigate changes in three-dimensional myocardial architecture during HHD progression in spontaneously hypertensive rats (SHRs).
  • To correlate extracellular matrix remodeling with the development of heart failure stages.
  • To determine the role of myocardial structural changes in left ventricular (LV) dysfunction.

Main Methods:

  • Longitudinal study of SHRs and Wistar-Kyoto controls from 3 to 24 months.
  • Hemodynamic measurements, echocardiography, and brain natriuretic peptide levels to define disease stages.
  • In vitro pressure-volume analysis and extended-volume confocal microscopy of LV transmural specimens for 3D myocardial architecture quantification.

Main Results:

  • Four disease stages identified: hypertension, diastolic dysfunction, early systolic failure, and decompensated HF.
  • Progressive increase in collagen fraction and myocyte cross-section in SHRs from 12 months.
  • Disruption and thickening of perimysial collagen, leading to dispersion and disorder of myocardial muscle layers.

Conclusions:

  • Left ventricular dilatation in decompensated HF is not due to LV softening.
  • Collagen networks are remodeled but not dissolved in this HHD model.
  • Progressive disruption of myocardial laminar organization likely contributes to systolic dysfunction in HHD.

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...